These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4220080)

  • 1. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regimens of chemotherapy for pulmonary tuberculosis--second report. A Hong Kong Tuberculosis Treatment Services/British Medical Research Council Investigation.
    Tubercle; 1974 Sep; 55(3):169-92. PubMed ID: 4220080
    [No Abstract]   [Full Text] [Related]  

  • 2. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Am Rev Respir Dis; 1972 Jul; 106(1):1-22. PubMed ID: 4624794
    [No Abstract]   [Full Text] [Related]  

  • 3. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.
    Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4620294
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
    Aquinas M
    Bull Int Union Tuberc; 1978 Dec; 53(4):253. PubMed ID: 387136
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
    Am Rev Respir Dis; 1989 Apr; 139(4):871-6. PubMed ID: 2648911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1987 Dec; 136(6):1339-42. PubMed ID: 2891333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of the Hong Kong/British Medical Research Council second controlled trial of short-course antituberculosis regimens [proceedings].
    Pang SC
    Tubercle; 1978 Mar; 59(1):64. PubMed ID: 345573
    [No Abstract]   [Full Text] [Related]  

  • 8. A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1980 Sep; 122(3):417-24. PubMed ID: 7416617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.
    Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4283482
    [No Abstract]   [Full Text] [Related]  

  • 10. Modern short-course regimens in the treatment of tuberculosis.
    Fox W
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):122-32. PubMed ID: 2999948
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of microbiological research in correcting the antibacterial therapy of tuberculosis].
    Dolzhanskiĭ VM; Sagalovich VIa
    Ter Arkh; 1987; 59(7):77-80. PubMed ID: 3118492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
    Saltini C; Velluti G; Mantovani P
    Arch Monaldi; 1978; 33(4):251-79. PubMed ID: 116622
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy in Hong Kong.
    Horsfall PA
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():52. PubMed ID: 4145680
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of thiacetazone plus isoniazid in Hong Kong: a Hong Kong tuberculosis treatment service-British Medical Research Council investigation.
    Horsfall PA
    Tubercle; 1968 Mar; 49():Suppl:30-2. PubMed ID: 4173325
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
    Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of pulmonary tuberculosis in Britain.
    Drug Ther Bull; 1988 Jan; 26(1):1-4. PubMed ID: 3123192
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of policies of sensitivity testing of tubercle bacilli in Hong Kong.
    Mitchison DA
    BTTA Rev; 1972 Jun; 2(2):34-5. PubMed ID: 4624665
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Hong Kong Chest Service/British Medical Research Council.
    Tubercle; 1982 Jun; 63(2):89-98. PubMed ID: 6758252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-, 5- and 6-month regimens containing isoniazid, rifampicin, pyrazinamide and streptomycin for treatment of pulmonary tuberculosis under program conditions in Hong Kong.
    Chan SL; Wong PC; Tam CM
    Tuber Lung Dis; 1994 Aug; 75(4):245-50. PubMed ID: 7949069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.